1-3 of 3
Chiaki Naito
Close
Sort by
Journal Articles

Clinical Significance of Additional Cytogenetic Abnormalities (ACA) at Disease Progression in Patients with High-Risk Myelodysplastic Syndrome (MDS) Treated with Azacitidine

Chiaki Naito, MD, Hiroaki Shimizu, MD PhD, Yuri Miyazawa, MD PhD, Takuma Ishizaki, MD PhD, Akihiko Yokohama, MD PhD, Takayuki Saito, MD PhDProf, Norifumi Tsukamoto, MD PhD, Hiroshi Handa, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5434.
https://doi.org/10.1182/blood-2019-127956
Published: 2019
Journal Articles

Risk Factors for Central Nervous System (CNS) Relapse after Autologous Stem Cell Transplant (ASCT) in Diffuse Large B-Cell Lymphoma (DLBCL)

Yukie Terasaki, MD, Hiroaki Shimizu, MD PhD, Yuri Miyazawa, MD PhD, Kohtaro Toyama, MD PhD, Hiromi Koiso, MD PhD, Akihiko Yokohama, MD PhD, Morio Matsumoto, MD, Hidemi Ogura, Chiaki Naito, MD, Norifumi Tsukamoto, MD PhD, Hiroshi Handa, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5344.
https://doi.org/10.1182/blood-2019-127990
Published: 2019
Journal Articles

Stem Cell Mobilization with High-Dose VP-16 Is Not Associated with an Increased Risk of Secondary MDS/AML after Autologous Transplant Against Malignant Lymphoma

Chiaki Naito, Hiroaki Shimizu, Yuri Miyazawa, Kohtaro Toyama, MD PhD, Takeki Mitsui, Hiromi Koiso, MD PhD, Hidemi Ogura, Morio Matsumoto, MD, Akihiko Yokohama, MD PhD, Norifumi Tsukamoto, MD PhD, Yoshihisa Nojima, Hiroshi Handa, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3445.
https://doi.org/10.1182/blood.V128.22.3445.3445
Published: 2016